Resources

392 Resources for

pharmaceutical company

Subscribe to this listing via:
RSS
Email

BNET Resources

How Pharma's CEO Pay Packages Measure Up: Since I've just spend close to a half-hour flipping through Big Pharma proxy filings, I figured I'd take just a little longer and put together a quick table of the best-paid chief executives in pharma and biotech. Enjoy. The following data is all taken from 2007 proxy...; Tags: Pharmaceutical Company, David P. Hamilton; Blog posts 2008-04-24
Congress Might Mandate a Federal Drug-Tracking System: Over the past few years, a rise in counterfeit versions of name-brand drugs has generated a fair amount of concern within government and the drug industry. (The growing scandal over tainted heparin, while a separate issue, hasn't helped.) And yet drugmakers have balked at current plans to track genuine drugs...; Tags: Industry, U.S. Congress, Pharmaceutical Company, David P. Hamilton; Blog posts 2008-04-30
More Internet Marketing Looms in Pharma's Future: By some reports, direct-to-consumer (DTC) drug advertising is beginning to stagnate -- a trend suggested by Sepracor's recent decision to cut back on TV spots involving its Lunesta moth. Stepping into the breach: More direct-marketing advertising, particularly involving the Internet. According to a...; Tags: Direct Marketing, Pharmaceutical Company, Internet Marketing, DMA, Internet, Sales Channel, Advertising & Promotion, Marketing Research, Sales, Marketing, David P. Hamilton; Blog posts 2008-04-25
Guerrilla Marketing, Pharma Style: The pharma blogosphere is buzzing about what appears to be a new "guerilla marketing" campaign for the over-the-counter allergy drug Zyrtec. According to one blogger in Boston and another in New York, many of these seemingly handwritten flyers have been seen taped to telephone poles, scaffolds and...; Tags: Marketing, Advertisement, Phone, Pharmaceutical Company, Phone Number, Telecom & Utilities, David P. Hamilton; Blog posts 2008-04-21
Life Without Blockbusters: What Valeant's Woes Portend for Pharma: It's now a truism that the drug industry's "blockbuster model" has pretty much had its day. Much of Big Pharma is having a terrible time winning approval for new drugs and even keeping up sales of existing blockbusters, in part because their underlying rationale -- that pushing drugs into mass...; Tags: Pharmaceutical Company, Blockbuster, Drug, Valeant, David P. Hamilton; Blog posts 2008-05-05

Man Bites Dog: Former Merck CEO Blasts High Drug Prices: Most pharmaceutical companies insist that high drug prices are a natural consequence of the risky business of drug discovery, and that huge profits on marketed drugs are necessary to cover the costs of the 5,000 to 10,000 experimental drugs that fail for every one that succeeds. In fact, there are...; Tags: Industry, Dr., Merck & Co. Inc., Pharmaceutical Company, Drug, Pricing, Strategy, Marketing, Management, David P. Hamilton; Blog posts 2008-05-05
Glaxo Makes Like Ponce de Leon With Sirtris Buy: You can't fault GlaxoSmithKline for temerity. The U.K. drugmaker's unexpectedly large $720 million bid for Sirtris Pharmaceuticals represents a gutsy bet that the Massachusetts biotech really has a handle on a class of drugs that slow aging. Not that anyone at either company is eager to describe their work that...; Tags: Pharmaceutical Company, Drug, Glaxo, Sirtris, Biotechnology, David P. Hamilton; Blog posts 2008-04-22
The Rise of the Paraprofessional: The loud drumbeat about the tough labor market often drowns out one fact: the need for skilled technologists, both chemical-based laboratory technicians and process technologists, is growing faster than the available pool of talent. Pharmaceutical and biopharmaceutical manufacturing companies are having a hard time hiring and retaining the skilled staff...; Tags: Workforce management, pharmaceutical company, training, biotechnology, talent, hiring; White papers
PAT Brings Laboratory Analysis Online: Among the U.S. Food and Drug Administration's (FDA) latest admonishments to the pharmaceutical manufacturing community is for the increased use of Process Analytical Technology (PAT). Broadly defined, PAT encompasses a variety of tools, technologies and methodologies designed to shift the industry's quality focus from post-production inspection to building quality into...; Tags: Federal government, FDA, pharmaceutical company, manufacturing, risk analysis, tool, industry; White papers
FDA May Lead Industry to Water, But Will It Drink?: If the processes in any pharmaceutical industry are under control and well understood, Food and Drug Administration (FDA) can do things very differently. Janet Woodcock, director of FDA's Center for Drug Evaluation and Research (CDER) joined a panel of pharmaceutical manufacturing executives for the keynote discussion at Interphex conference in...; Tags: Federal government, FDA, pharmaceutical company, conference, beverage, industry, manufacturing; White papers
Intrapac Sees 20/20: IntraPac manufactures a full range of metal and laminate tubes along with complementary closures, including tamper-evident designs. The paper depicts that the company introduced Metered-Dose Inhaler (MDI) coating technology to the global pharmaceutical market. MDI coatings are applied to metered-dose aerosol cans used with prescription grade medication for asthma. A...; Tags: ozone, wall; White papers
Space-Saving Machine Counts, Fills and Caps: The paper talks about RTC80 machine that measures only 1.4 by 1.74 meters yet incorporates counting, filling and capping functions in a single machine. In addition to its space-saving footprint, the machine is uniquely suited to sterile tablet and capsule packaging applications. With a capacity of up to 60 100-count...; Tags: tablet; White papers
Ion Spectrometry to Cut Cleaning Validation Time: Cleaning validation is a critical part of current Good Manufacturing Practice (cGMP), requiring manufacturers to spell out, and then verify, the procedures that they use to clean their equipment. After cleaning, operators typically use High Pressure Liquid Chromatography (HPLC) to sample reference materials which is time-consuming, and facilities can be...; Tags: Manufacturing; White papers
Whistleblower or Disgruntled Employee? Lawsuit Alleges cGMP Violations: In a case that could set a precedent for drug manufacturers if it reaches the courtroom, Mark Livingston, former associate director of training and continuous improvement at Wyeth Pharmaceuticals' Sanford, N.C. plant, has invoked the employee protection provisions of the Sarbanes-Oxley Act of 2002 to sue his former employer as...; Tags: Workforce management, training, director, Sarbanes-Oxley Act, Human Resources, compliance, manufacturing; White papers
The Future of Drugmaking: Rising demand from aging, health-conscious baby-boomers promises to keep pharmaceutical manufacturing plants humming for many years to come. Genetics and biochemistry promise new generations of small-molecule and protein products, gene therapies, viral vectors, personalized medicine, and ever more-complex delivery and dosage forms. The more esoteric of these products may still...; Tags: pharmaceutical company, manufacturing, health care, industry; White papers
A Little Knowledge Remains a Dangerous Thing: As the blockbuster drug model fades, and more companies scrutinize their manufacturing operations more closely, a growing number are deploying Process Analytical Technologies (PAT) to gain process enlightenment. Some drug manufacturers such as Pfizer, with its Right First Time initiative, have made deeper process knowledge the cornerstone of corporate programs....; Tags: knowledge, manufacturing, monitor; White papers
Overview of the OIG Compliance Program Guidance for Pharmaceutical Manufacturers: On April 23, 2003, the Office of Inspector General (OIG) of the Department of Health and Human Services released the final Compliance Program Guidance for Pharmaceutical Manufacturers. The Guidance applies to companies that develop, manufacture, market, and sell pharmaceutical drugs or biological products, and is intended to assist these companies...; Tags: Vertical industries, Manufacturing, HEALTHCARE, Benefits, Protiviti, pharmaceutical company, health care, manufacturer, compliance, medical device; White papers
The Long Arm of S88: Batch automation standards are having an impact far from the control room, changing approaches to plant design, specification, and validation. Modular construction is helping drug makers manage these pressures in new plant construction. But for plant design, specification and validation, standards developed in the process control field are having a...; Tags: Quality, specification, standards, manufacturing; White papers
Can a New Lead Drug Be Developed? Ask Manufacturing, Early and Often: A good deal has been written lately about the "attrition rates" of new drug discoveries. A growing number of promising new leads ultimately prove to be too insoluble or unstable to be formulated. This problem is evident in the declining rate of new drug approvals. Fewer drugs and biologicals make...; Tags: manufacturing; White papers
S88 Redefines Clean in Place Operations: Class-based programming simplifies design, testing and validation of reusable modules, such as those found in CIP processes. This article highlights S88 as an internationally recognized standard that emphasizes good automation practices, is suitable for a broad variety of batch processes, is effective for any degree of automation being applied, and...; Tags: programming; White papers